Free Trial

Terumo (OTCMKTS:TRUMY) Share Price Crosses Above 50 Day Moving Average - Time to Sell?

Terumo logo with Medical background

Key Points

  • Terumo Corp.'s stock price crossed above its **50-day moving average** of $17.78, reaching a high of **$18.34** during trading.
  • The company reported **$0.08 earnings per share (EPS)** for the last quarter, which was **below analysts' estimates** of $0.15.
  • Terumo has a **market cap of $26 billion** and a **debt-to-equity ratio of 0.12**, indicating a solid financial position relative to its liabilities.
  • Looking to export and analyze Terumo data? Unlock 5 Weeks of MarketBeat All Access for Just $5. Claim Your Limited-Time Discount.

Terumo Corp. (OTCMKTS:TRUMY - Get Free Report) shares passed above its 50 day moving average during trading on Thursday . The stock has a 50 day moving average of $17.78 and traded as high as $18.34. Terumo shares last traded at $17.56, with a volume of 389,522 shares trading hands.

Terumo Stock Performance

The stock's 50-day moving average is $17.73 and its 200 day moving average is $18.34. The firm has a market cap of $25.67 billion, a P/E ratio of 33.35 and a beta of 0.79. The company has a debt-to-equity ratio of 0.12, a quick ratio of 1.78 and a current ratio of 3.00.

Terumo (OTCMKTS:TRUMY - Get Free Report) last released its earnings results on Wednesday, May 14th. The company reported $0.08 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $0.15 by ($0.07). The firm had revenue of $1.79 billion for the quarter, compared to the consensus estimate of $1.79 billion. Terumo had a return on equity of 8.48% and a net margin of 11.28%.

Terumo Company Profile

(Get Free Report)

Terumo Corporation engages in the manufacture and sale of medical products and equipment in Japan, Europe, China, the United States, Asia, and internationally. The company operates through three segments: Cardiac and Vascular Company, Medical Care Solutions Company, and Blood and Cell Technologies Company.

Featured Stories

Should You Invest $1,000 in Terumo Right Now?

Before you consider Terumo, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Terumo wasn't on the list.

While Terumo currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Metaverse Stocks And Why You Can't Ignore Them Cover

Thinking about investing in Meta, Roblox, or Unity? Enter your email to learn what streetwise investors need to know about the metaverse and public markets before making an investment.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Follow the Money: 5 Stocks Institutions Are Buying NOW
Strong Earnings? Market Says NVIDIA-Level Growth or Be Forgotten
Palantir’s Soaring Valuation—Justified or Overhyped?

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines